The Food and Drug Administration is asking Eli Lilly to gather more safety data on its new weight loss pill, Foundayo, ...

At the heart of the request is whether taking Foundayo - made with a new active ingredient called orforglipron - could be ...

The daily pill, called Foundayo, could make it easier for more people to lose weight.

Federal regulators on Wednesday approved Eli Lilly’s new weight-loss pill, a second daily oral medication to treat obesity ...

By Sriparna Roy April 14 (Reuters) - The U.S. Food and Drug Administration has asked Eli Lilly for more data on liver injury ...

The Food and Drug Administration on Wednesday approved Eli Lilly's pill version of a GLP-1 medication for weight loss.

The pill will be branded as Foundayo and shipping will begin on Monday and be available at pharmacies and on telehealth platforms “shortly after,” according to Eli Lilly. People with insurance may be ...

By Mrinalika Roy April 1 (Reuters) - Eli Lilly shares jumped nearly 6% on Wednesday after the U.S. Food and Drug ...

Foundayo, a trademarked version of orforglipron, acts like the popular injectable medications that control appetite and ...

The Federal Drug Administration (FDA) has approved a new once-daily weight-loss pill from Eli Lilly, adding to the bevy of ...

The daily pill, called Foundayo, is the second oral GLP-1 product to reach the market over the past few months.

A new daily pill, called Foundayo, is the second oral GLP-1 to reach the market in recent months, following the FDA approval ...